📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Cagent Vascular

1.1 - Company Overview

Cagent Vascular Logo

Cagent Vascular

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of serration technology for treating cardiovascular disease, offering the Serranator PTA Serration Balloon Catheter, an angioplasty device with serrated metal strips on a semi-compliant balloon that creates multiple longitudinal micro-serrations to aid arterial expansion.

Products and services

  • Cardiovascular Serration Technology Platform: Platform-level serration technology engineered to improve cardiovascular disease treatment by enabling interrupted micro-serrations and arterial expansion
  • Serranator PTA Serration Balloon Catheter: Catheter-based angioplasty device with serrated metal strips embedded on a semi-compliant balloon creating multiple longitudinal interrupted micro-serrations aiding arterial expansion
  • Micro-Serration Arterial Expansion Method: Device-integrated technique forming multiple longitudinal lines of interrupted micro-serrations via serrated metal strips embedded on a semi-compliant balloon to assist arterial expansion

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Cagent Vascular

LeMaitre Logo

LeMaitre

HQ: United States Website
  • Description: Provider of medical devices and implants for the treatment of peripheral vascular diseases, including RestoreFlow, a tissue processing division supplying human tissue allografts for peripheral vascular and cardiac disease, and the LeMaitre Valvulotome, a device that cuts valves in peripheral veins without direct vision for lower extremity arterial disease.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full LeMaitre company profile →
RR Mechatronics Logo

RR Mechatronics

HQ: The Netherlands Website
  • Description: Provider of analytics laboratory instruments for the medical diagnosis industry.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full RR Mechatronics company profile →
Atacor Logo

Atacor

HQ: United States Website
  • Description: Provider of extravascular cardiac lead systems enabling defibrillation, bradycardia pacing, and anti-tachycardia pacing without contacting the heart or vascular system, including the AtaCor EV-ICD Lead System and the EV Temporary Pacing Lead System that provides pacing support via a parasternal approach.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Atacor company profile →
Exithera Pharmaceuticals Logo

Exithera Pharmaceuticals

HQ: United States Website
  • Description: Provider of antithrombotic and stroke prevention drug development, offering novel, potent, selective small-molecule Factor XIa inhibitors, including frunexian to prevent thrombosis without increased bleeding risk, and EP-7041 evaluated in a Phase 2 trial to prevent thrombosis in COVID-19 ICU patients and investigated to inhibit ECMO-related thrombosis while minimizing bleeding risk.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Exithera Pharmaceuticals company profile →
Recovery Force Logo

Recovery Force

HQ: United States Website
  • Description: Provider of MORPH, an on-body pre recovery and performance enhancement system, developed and manufactured by Recovery Force.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Recovery Force company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Cagent Vascular

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Cagent Vascular

2.2 - Growth funds investing in similar companies to Cagent Vascular

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Cagent Vascular

4.2 - Public trading comparable groups for Cagent Vascular

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Cagent Vascular

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Cagent Vascular

What does Cagent Vascular do?

Cagent Vascular is a provider of serration technology for treating cardiovascular disease, offering the Serranator PTA Serration Balloon Catheter, an angioplasty device with serrated metal strips on a semi-compliant balloon that creates multiple longitudinal micro-serrations to aid arterial expansion.

Who are Cagent Vascular's competitors?

Cagent Vascular's competitors and similar companies include LeMaitre, RR Mechatronics, Atacor, Exithera Pharmaceuticals, and Recovery Force.

Where is Cagent Vascular headquartered?

Cagent Vascular is headquartered in United States.

How many employees does Cagent Vascular have?

Cagent Vascular has 1,000 employees 🔒.

When was Cagent Vascular founded?

Cagent Vascular was founded in 2010 🔒.

What sector and industry vertical is Cagent Vascular in?

Cagent Vascular is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Cagent Vascular

Who are the top strategic acquirers in Cagent Vascular's sector and industry

Top strategic M&A buyers and acquirers in Cagent Vascular's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Cagent Vascular?

Top strategic M&A buyers groups and sectors for Cagent Vascular include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Cagent Vascular's sector and industry vertical

Which are the top PE firms investing in Cagent Vascular's sector and industry vertical?

Top PE firms investing in Cagent Vascular's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Cagent Vascular's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Cagent Vascular's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Cagent Vascular's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Cagent Vascular include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Cagent Vascular's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Cagent Vascular?

The key public trading comparables and valuation benchmarks for Cagent Vascular include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Cagent Vascular for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Cagent Vascular with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Cagent Vascular's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Cagent Vascular with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Cagent Vascular's' sector and industry vertical?

Access recent funding rounds and capital raises in Cagent Vascular's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Cagent Vascular

Launch login modal Launch register modal